Skip to main content
. 2022 Sep 26;11(4):1749–1766. doi: 10.1007/s40120-022-00406-z
Clopidogrel, which is frequently used to prevent ischemic stroke, may cause treatment resistance and lead to recurrence of stroke.
Overall, 206 participants who received clopidogrel treatment were enrolled in the study. The participants were further divided into the modification (39 patients) and no modification (167 patients) groups.
Modification based on the platelet reactivity unit (PRU) cutoff value significantly improved the outcomes of the per protocol set population after adjusting for severe cerebral artery stenosis.
Clopidogrel therapy with a PRU cutoff value of 190 may be considered to improve outcomes.